Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RXRX

Recursion Pharmaceuticals Inc

Apr 18 • 04:00PM ET

7.40

Dollar change -0.07
Percentage change -0.94	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKK ARKG VTI VB IWM VBK VXF IWN IBB SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.55	Insider Own	32.04%	Shs Outstand	226.26M	Perf Week	-17.04%
Market Cap	1.60B	Forward P/E	-	EPS next Y	-1.86	Insider Trans	-1.60%	Shs Float	146.68M	Perf Month	-31.16%
Income	-328.07M	PEG	-	EPS next Q	-0.42	Inst Own	77.36%	Short Float	27.11%	Perf Quarter	-25.18%
Sales	44.58M	P/S	35.83	EPS this Y	-9.14%	Inst Trans	4.61%	Short Ratio	6.22	Perf Half Y	13.50%
Book/sh	1.98	P/B	3.73	EPS next Y	-7.82%	ROA	-48.42%	Short Interest	39.76M	Perf Year	24.58%
Cash/sh	1.83	P/C	4.05	EPS next 5Y	12.00%	ROE	-69.12%	52W Range	4.54 - 16.75	Perf YTD	-24.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-43.41%	ROI	-64.59%	52W High	-55.81%	Beta	0.87
Dividend TTM	-	Quick Ratio	4.70	Sales past 5Y	132.77%	Gross Margin	-37.61%	52W Low	63.00%	ATR (14)	0.63
Dividend Ex-Date	-	Current Ratio	4.70	EPS Y/Y TTM	-13.81%	Oper. Margin	-808.21%	RSI (14)	28.97	Volatility	5.54% 5.62%
Employees	-	Debt/Eq	0.11	Sales Y/Y TTM	11.88%	Profit Margin	-735.99%	Recom	2.43	Target Price	13.00
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-28.81%	Payout	-	Rel Volume	0.45	Prev Close	7.47
Sales Surprise	-46.60%	EPS Surprise	6.40%	Sales Q/Q	-20.36%	Earnings	Feb 27 AMC	Avg Volume	6.39M	Price	7.40
SMA20	-19.87%	SMA50	-31.14%	SMA200	-20.79%	Trades		Volume	2,859,000	Change	-0.94%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-23	Initiated	Morgan Stanley	Equal-Weight	$8
Mar-16-23	Initiated	Needham	Buy	$17
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$20
Apr-18-22	Downgrade	BofA Securities	Buy → Neutral	$10
Mar-04-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$10
Sep-21-21	Initiated	Berenberg	Buy	$37
May-11-21	Initiated	SVB Leerink	Outperform	$33
May-11-21	Initiated	KeyBanc Capital Markets	Overweight	$36
May-11-21	Initiated	JP Morgan	Neutral	$32
May-11-21	Initiated	Goldman	Neutral	$34
May-11-21	Initiated	BofA Securities	Buy	$31

Show Previous Ratings

Apr-17-24 05:50PM	Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know (Zacks)
07:00AM	Where Will Recursion Pharmaceuticals Be in 5 Years? (Motley Fool)
Apr-16-24 08:00AM	Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer (GlobeNewswire)
Apr-10-24 05:50AM	Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take. (Motley Fool) -5.61%
Apr-08-24 09:00AM	The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation (Motley Fool)
08:45AM	Loading…
Apr-04-24 08:45AM	Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy? (Motley Fool)
01:31AM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares (GuruFocus.com)
Apr-03-24 09:35AM	Down -26.36% in 4 Weeks, Here's Why Recursion Pharmaceuticals (RXRX) Looks Ripe for a Turnaround (Zacks)
Apr-02-24 08:00AM	Recursion to Participate in Upcoming Investor Conference (GlobeNewswire) -6.40%
Apr-01-24 12:00PM	All You Need to Know About Recursion Pharmaceuticals (RXRX) Rating Upgrade to Buy (Zacks) -6.02%
Mar-26-24 08:00AM	Recursion Publishes Annual Environmental, Social and Governance Report (GlobeNewswire)
Mar-22-24 01:29AM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares (GuruFocus.com)
Mar-18-24 01:00PM	New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence (Benzinga)
Mar-15-24 04:54PM	Since Nvidia Disclosed Stakes in These Stocks, They've Soared (Investopedia)
01:49AM	Recursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares (GuruFocus.com)
04:00AM	Loading…
Mar-11-24 04:00AM	Recursion Announces Plans to Open New Office in London (GlobeNewswire) -7.33%
Mar-07-24 10:28AM	Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst (Motley Fool)
Mar-01-24 02:58PM	Recursion Hosts Second Annual Rare Disease Day Events for Utah's Rare Disease Community (GlobeNewswire)
02:00PM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? (InvestorPlace)
07:59AM	Recursion to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-28-24 06:44PM	Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today (Motley Fool) -16.62%
10:56AM	Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 06:35PM	Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +5.15%
05:42PM	Recursion Pharmaceuticals: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	Recursion Pharmaceuticals Inc (RXRX) Reports Mixed Financial Results Amidst Advancements in ... (GuruFocus.com)
04:05PM	Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
Feb-24-24 03:08AM	Recursion Pharmaceuticals Inc President and COO Tina Marriott Sells 8,000 Shares (GuruFocus.com)
Feb-22-24 09:37AM	These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours? (Motley Fool) +21.26%
Feb-21-24 11:27PM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares (GuruFocus.com)
Feb-20-24 07:59AM	Recursion to Host Public L(earnings) Call on February 27 (GlobeNewswire)
05:13PM	Loading…
Feb-19-24 05:13PM	Double Your Money: 3 Growth Stocks to Grab in 2024 (InvestorPlace)
10:00AM	Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks. (Motley Fool)
Feb-18-24 09:00AM	Get Rich Quick With These 3 AI Stocks to Buy Now (InvestorPlace)
Feb-16-24 10:50AM	The Nvidia stock surge is now extending to other companies (Quartz) +5.79%
02:53AM	Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? (Zacks)
Feb-15-24 06:27PM	Why Recursion Pharmaceuticals Stock Zoomed Higher on Thursday (Motley Fool) +13.83%
04:17PM	Nvidia Discloses Stakes In Arm, SoundHound AI, Nano-X And More (Investor's Business Daily)
03:46PM	Nvidia bets on AI future with new investments, shares rally (Yahoo Finance Video)
03:17PM	Nvidia's investments in these AI companies sent their stocks soaring (Yahoo Finance)
Feb-10-24 02:58AM	Recursion Pharmaceuticals Inc CEO Christopher Gibson Sells 48,272 Shares (GuruFocus.com)
Feb-09-24 02:23AM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares (GuruFocus.com)
Feb-08-24 10:30AM	2 Cathie Wood Stocks With Jaw-Dropping Growth Potential (Motley Fool) +8.43%
Feb-07-24 10:00AM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You? (Motley Fool)
Jan-29-24 05:49PM	20 Countries With The Highest Life Expectancy in the World (Insider Monkey) +10.02%
Jan-28-24 08:45AM	2 Under-the-Radar Stocks With Incredible Upside Potential (Motley Fool)
Jan-27-24 01:04PM	Baillie Gifford Reduces Stake in Recursion Pharmaceuticals Inc (GuruFocus.com)
Jan-25-24 11:52PM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares (GuruFocus.com)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week (Motley Fool)
Jan-24-24 09:00AM	Altitude Lab Startups Raise Over $120M in Capital (GlobeNewswire)
Jan-18-24 09:01PM	Recursion Pharmaceuticals Inc Insider Sells Shares (GuruFocus.com)
Jan-15-24 08:45AM	3 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Jan-13-24 05:20AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week (Motley Fool)
Jan-12-24 06:11AM	Recursions Chris Gibson on AI in biotech and virtuous cycles (BioPharma Dive)
Jan-11-24 01:11PM	40 Cities with the Lowest Life Expectancy in the US (Insider Monkey) -9.93%
Jan-09-24 02:16PM	Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock (InvestorPlace) +6.26%
Jan-08-24 10:59AM	Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference (GlobeNewswire) +5.70%
08:23AM	Recursion Pharmaceuticals (RXRX) Soars 7.4%: Is Further Upside Left in the Stock? (Zacks)
Jan-04-24 07:59AM	Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline (GlobeNewswire) +14.65%
Jan-03-24 11:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024 (Motley Fool)
08:00AM	Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8 (GlobeNewswire)
Jan-02-24 01:57PM	3 Biotech Stocks at the Forefront of the Quest for Eternal Youth (InvestorPlace)
Dec-29-23 07:02PM	Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares (GuruFocus.com) -7.07%
Dec-22-23 06:22AM	40 Cities with the Highest Life Expectancy in the US (Insider Monkey)
Dec-20-23 07:59AM	Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry (GlobeNewswire) -5.78%
Dec-19-23 12:44PM	3 Genomics Stocks to Unlock the Future of Medicine (InvestorPlace) +6.24%
Dec-17-23 11:30AM	2 Cathie Wood Stocks That Might Be Smart Buys Right Now (Motley Fool)
Dec-16-23 01:00PM	AI Meets Biotech: 3 Top Stocks Transforming Medical Science (InvestorPlace)
Dec-15-23 03:06AM	Insider Sell: CFO Michael Secora Sells 50,000 Shares of Recursion Pharmaceuticals Inc (RXRX) (GuruFocus.com)
Dec-14-23 02:31PM	Recursion Pharmaceuticals Stock (NASDAQ:RXRX): Small Company, Big Future (TipRanks) +14.41%
Dec-09-23 11:06AM	Insider Sell: CEO Christopher Gibson Disposes of 59,829 Shares of Recursion Pharmaceuticals Inc ... (GuruFocus.com)
Nov-28-23 10:36AM	Cathie Wood picks up nearly 2 million shares of struggling, cheap stock (TheStreet.com) +7.50%
Nov-26-23 09:30AM	Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters. (Motley Fool)
Nov-22-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
09:45AM	This Stock Could Soar by 120%, According to Wall Street (Motley Fool)
Nov-21-23 08:00AM	Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off? (Motley Fool)
Nov-18-23 01:13AM	Insider Sell Alert: Chief Business Officer Shafique Virani Sells 18,000 Shares of Recursion ... (GuruFocus.com)
Nov-17-23 01:06AM	Insider Sell: CFO Michael Secora Offloads 50,000 Shares of Recursion Pharmaceuticals Inc (RXRX) (GuruFocus.com) +5.70%
Nov-15-23 08:41AM	Cathie Wood snaps up nearly 4 million shares of a surging, cheap stock (TheStreet.com) +11.15%
Nov-09-23 07:11PM	AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence (InvestorPlace) -7.10%
09:41AM	Bayer and Recursion Focus Research Collaboration on Oncology (GlobeNewswire)
08:02AM	Recursion Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
08:01AM	Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology (GlobeNewswire)
07:58AM	Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-08-23 02:35PM	3 Stocks to Buy for Their Proximity to Nvidia (InvestorPlace) -7.86%
Nov-02-23 08:05AM	Recursion to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-01-23 06:57AM	The 7 Best Cathie Wood Stocks to Buy Now: November Edition (InvestorPlace)
Oct-31-23 09:45AM	2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell (Motley Fool)
Oct-26-23 11:01PM	3 Extra-Speculative Stocks That Could Make You Very, Very Rich (InvestorPlace)
Oct-18-23 10:23PM	Insider Sell: Chief Business Officer Shafique Virani Sells 18,000 Shares of Recursion ... (GuruFocus.com) -5.06%
Oct-17-23 09:53AM	2 Risky Stocks With Massive Potential (Motley Fool)
Oct-13-23 06:00AM	1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid (Motley Fool)
05:02AM	Insider Sell: CFO Michael Secora Sells 50,000 Shares of Recursion Pharmaceuticals Inc (RXRX) (GuruFocus.com)
Oct-11-23 10:07AM	Is Recursion Pharmaceuticals Stock a Buy Now? (Motley Fool)
Oct-06-23 11:00PM	CEO Christopher Gibson Sells 59,794 Shares of Recursion Pharmaceuticals Inc (RXRX) (GuruFocus.com)
Oct-05-23 08:45AM	2 Cathie Wood Stocks I'm Bullish On (Motley Fool)
Oct-04-23 09:15AM	2 AI Stocks That Aren't Worth the Hype (Motley Fool)
Oct-02-23 10:45AM	2 Cathie Wood Stocks That Could Deliver Exponential Returns (Motley Fool) -6.41%
Sep-30-23 09:15AM	Is Recursion Pharmaceuticals Stock a Buy? (Motley Fool)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Secora Michael	Chief Financial Officer	Apr 17 '24	Option Exercise	2.22	37,500	83,250	1,254,179	Apr 18 05:12 PM
Secora Michael	Chief Financial Officer	Apr 17 '24	Sale	7.58	23,124	175,349	1,231,055	Apr 18 05:12 PM
Secora Michael	Chief Financial Officer	Apr 16 '24	Option Exercise	2.22	37,500	83,250	1,241,679	Apr 18 05:12 PM
Secora Michael	Chief Financial Officer	Apr 16 '24	Sale	7.67	25,000	191,658	1,216,679	Apr 18 05:12 PM
Borgeson Blake	Director	Apr 16 '24	Sale	7.66	11,447	87,725	7,229,861	Apr 18 05:12 PM
Gibson Christopher	Chief Executive Officer	Apr 04 '24	Sale	9.02	40,000	360,800	938,524	Apr 05 05:44 PM
Gibson Christopher	Chief Executive Officer	Apr 04 '24	Sale	9.02	25,000	225,500	0	Apr 05 05:44 PM
Gibson Christopher	Chief Executive Officer	Apr 03 '24	Sale	8.84	40,000	353,600	978,524	Apr 05 05:44 PM
Gibson Christopher	Chief Executive Officer	Apr 03 '24	Sale	8.84	25,000	221,000	0	Apr 05 05:44 PM
Borgeson Blake	Director	Apr 02 '24	Sale	8.82	11,447	100,942	7,241,308	Apr 03 05:42 PM
Gibson Christopher	Chief Executive Officer	Mar 28 '24	Sale	10.10	40,000	404,000	1,043,524	Apr 01 06:40 PM
Gibson Christopher	Chief Executive Officer	Mar 28 '24	Sale	10.10	25,000	252,500	0	Apr 01 06:40 PM
Marriott Tina	President and COO	Mar 21 '24	Option Exercise	1.06	8,000	8,480	647,982	Mar 25 06:39 PM
Marriott Tina	President and COO	Mar 21 '24	Sale	10.75	8,000	85,980	639,982	Mar 25 06:39 PM
Borgeson Blake	Director	Mar 19 '24	Sale	10.79	20,054	216,423	7,252,755	Mar 21 05:38 PM
Secora Michael	Chief Financial Officer	Mar 13 '24	Option Exercise	2.22	37,500	83,250	1,229,179	Mar 14 07:28 PM
Secora Michael	Chief Financial Officer	Mar 13 '24	Sale	11.03	25,000	275,815	1,204,179	Mar 14 07:28 PM
Secora Michael	Chief Financial Officer	Mar 12 '24	Option Exercise	2.22	37,500	83,250	1,216,679	Mar 14 07:28 PM
Secora Michael	Chief Financial Officer	Mar 12 '24	Sale	10.46	25,000	261,375	1,191,679	Mar 14 07:28 PM
Gibson Christopher	Chief Executive Officer	Mar 06 '24	Option Exercise	4.42	39,924	176,384	1,144,843	Mar 08 07:08 PM
Gibson Christopher	Chief Executive Officer	Mar 06 '24	Sale	11.86	36,319	430,682	1,108,524	Mar 08 07:08 PM
Gibson Christopher	Chief Executive Officer	Mar 06 '24	Sale	11.55	25,000	288,823	0	Mar 08 07:08 PM
Borgeson Blake	Director	Mar 05 '24	Sale	12.06	20,054	241,805	7,272,809	Mar 07 06:53 PM
Marriott Tina	President and COO	Feb 22 '24	Option Exercise	1.06	8,000	8,480	647,982	Feb 23 07:22 PM
Marriott Tina	President and COO	Feb 22 '24	Sale	14.89	8,000	119,160	639,982	Feb 23 07:22 PM
Borgeson Blake	Director	Feb 20 '24	Sale	12.32	20,054	247,125	7,292,863	Feb 21 05:37 PM
Secora Michael	Chief Financial Officer	Feb 14 '24	Option Exercise	2.22	37,500	83,250	1,211,351	Feb 15 06:00 PM
Secora Michael	Chief Financial Officer	Feb 14 '24	Sale	10.46	25,000	261,425	1,186,351	Feb 15 06:00 PM
Secora Michael	Chief Financial Officer	Feb 13 '24	Option Exercise	2.22	37,500	83,250	1,198,851	Feb 15 06:00 PM
Secora Michael	Chief Financial Officer	Feb 13 '24	Sale	9.86	25,000	246,560	1,173,851	Feb 15 06:00 PM
Gibson Christopher	Chief Executive Officer	Feb 07 '24	Option Exercise	2.48	31,250	77,500	822,975	Feb 09 05:34 PM
Gibson Christopher	Chief Executive Officer	Feb 07 '24	Sale	9.22	48,272	444,981	774,703	Feb 09 05:34 PM
Borgeson Blake	Director	Feb 06 '24	Sale	9.30	11,447	106,489	7,312,917	Feb 08 06:54 PM
Larson Tina Marriott	President and COO	Jan 25 '24	Option Exercise	1.06	8,000	8,480	422,584	Jan 29 06:52 PM
Larson Tina Marriott	President and COO	Jan 25 '24	Sale	10.35	8,000	82,762	414,548	Jan 29 06:52 PM
Borgeson Blake	Director	Jan 23 '24	Sale	10.58	20,054	212,083	7,324,364	Jan 25 06:13 PM
Secora Michael	Chief Financial Officer	Jan 17 '24	Option Exercise	2.22	37,500	83,250	1,006,014	Jan 18 06:37 PM
Secora Michael	Chief Financial Officer	Jan 17 '24	Sale	10.25	25,000	256,348	981,014	Jan 18 06:37 PM
Secora Michael	Chief Financial Officer	Jan 16 '24	Option Exercise	2.22	37,500	83,250	993,514	Jan 18 06:37 PM
Virani Shafique	Chief Business Officer	Jan 16 '24	Option Exercise	2.22	18,000	39,960	154,748	Jan 18 06:39 PM
Secora Michael	Chief Financial Officer	Jan 16 '24	Sale	10.45	25,000	261,160	968,514	Jan 18 06:37 PM
Virani Shafique	Chief Business Officer	Jan 16 '24	Sale	10.93	18,000	196,740	136,748	Jan 18 06:39 PM
Li Dean Y	Director	Jan 09 '24	Sale	13.66	29,000	396,214	421,000	Jan 11 06:51 PM
Borgeson Blake	Director	Jan 09 '24	Sale	13.62	20,054	273,202	7,344,418	Jan 11 06:50 PM
Gibson Christopher	Chief Executive Officer	Jan 03 '24	Option Exercise	2.48	31,250	77,500	822,578	Jan 05 08:03 PM
Gibson Christopher	Chief Executive Officer	Jan 03 '24	Sale	9.49	30,853	292,804	791,725	Jan 05 08:03 PM
Gibson Christopher	Chief Executive Officer	Jan 03 '24	Sale	9.51	25,000	237,763	0	Jan 05 08:03 PM
Larson Tina Marriott	President and COO	Dec 28 '23	Option Exercise	1.06	8,000	8,480	422,548	Jan 02 04:58 PM
Larson Tina Marriott	President and COO	Dec 28 '23	Sale	10.58	8,000	84,654	414,548	Jan 02 04:58 PM
Borgeson Blake	Director	Dec 26 '23	Sale	10.63	20,054	213,144	7,364,472	Dec 28 05:48 PM
Virani Shafique	Chief Business Officer	Dec 15 '23	Option Exercise	2.22	18,000	39,960	154,748	Dec 19 07:22 PM
Virani Shafique	Chief Business Officer	Dec 15 '23	Sale	9.60	18,000	172,800	136,748	Dec 19 07:22 PM
Dar Zavain	Director	Dec 14 '23	Sale	9.00	20,141	181,269	53,823	Dec 18 06:44 PM
Secora Michael	Chief Financial Officer	Dec 13 '23	Option Exercise	2.22	37,500	83,250	981,014	Dec 14 06:53 PM
Secora Michael	Chief Financial Officer	Dec 13 '23	Sale	7.59	25,000	189,770	956,014	Dec 14 06:53 PM
Secora Michael	Chief Financial Officer	Dec 12 '23	Option Exercise	2.22	37,500	83,250	968,514	Dec 14 06:53 PM
Secora Michael	Chief Financial Officer	Dec 12 '23	Sale	7.39	25,000	184,868	943,514	Dec 14 06:53 PM
Borgeson Blake	Director	Dec 12 '23	Sale	7.40	11,447	84,693	7,384,526	Dec 14 06:51 PM
Gibson Christopher	Chief Executive Officer	Dec 06 '23	Option Exercise	2.48	31,250	77,500	851,157	Dec 08 05:22 PM
Gibson Christopher	Chief Executive Officer	Dec 06 '23	Sale	7.49	59,829	448,394	791,328	Dec 08 05:22 PM
Borgeson Blake	Director	Nov 28 '23	Sale	6.72	11,447	76,918	7,395,973	Nov 30 05:41 PM
Larson Tina Marriott	President and COO	Nov 16 '23	Option Exercise	1.06	3,000	3,180	416,404	Nov 17 05:53 PM
Larson Tina Marriott	President and COO	Nov 16 '23	Sale	6.76	3,000	20,280	413,404	Nov 17 05:53 PM
Secora Michael	Chief Financial Officer	Nov 15 '23	Option Exercise	2.22	37,500	83,250	963,186	Nov 16 06:54 PM
Virani Shafique	Chief Business Officer	Nov 15 '23	Option Exercise	2.22	18,000	39,960	158,351	Nov 17 05:52 PM
Secora Michael	Chief Financial Officer	Nov 15 '23	Sale	7.32	25,000	182,986	938,186	Nov 16 06:54 PM
Virani Shafique	Chief Business Officer	Nov 15 '23	Sale	6.51	18,000	117,180	140,351	Nov 17 05:52 PM
Secora Michael	Chief Financial Officer	Nov 14 '23	Option Exercise	2.22	37,500	83,250	950,686	Nov 16 06:54 PM
Secora Michael	Chief Financial Officer	Nov 14 '23	Sale	6.32	25,000	157,942	925,686	Nov 16 06:54 PM
Borgeson Blake	Director	Nov 14 '23	Sale	6.32	8,885	56,151	7,407,420	Nov 16 06:55 PM
Gibson Christopher	Chief Executive Officer	Nov 01 '23	Option Exercise	2.48	31,250	77,500	873,997	Nov 03 06:14 PM
Gibson Christopher	Chief Executive Officer	Nov 01 '23	Sale	5.20	37,177	193,306	836,820	Nov 03 06:14 PM
Gibson Christopher	Chief Executive Officer	Nov 01 '23	Sale	5.12	25,000	127,995	0	Nov 03 06:14 PM
Borgeson Blake	Director	Oct 31 '23	Sale	5.27	8,885	46,864	7,416,305	Nov 02 07:02 PM
Larson Tina Marriott	President and COO	Oct 26 '23	Option Exercise	1.06	3,000	3,180	421,782	Oct 30 06:26 PM
Larson Tina Marriott	President and COO	Oct 26 '23	Sale	5.63	3,000	16,885	418,782	Oct 30 06:26 PM
Borgeson Blake	Director	Oct 17 '23	Sale	6.58	8,885	58,483	7,425,190	Oct 19 05:34 PM
Virani Shafique	Chief Business Officer	Oct 16 '23	Option Exercise	2.22	18,000	39,960	158,351	Oct 18 05:34 PM
Virani Shafique	Chief Business Officer	Oct 16 '23	Sale	6.30	18,000	113,400	140,351	Oct 18 05:34 PM
Secora Michael	Chief Financial Officer	Oct 11 '23	Option Exercise	2.22	37,500	83,250	938,186	Oct 12 06:07 PM
Secora Michael	Chief Financial Officer	Oct 11 '23	Sale	6.85	25,000	171,312	913,186	Oct 12 06:07 PM
Secora Michael	Chief Financial Officer	Oct 10 '23	Option Exercise	2.22	37,500	83,250	925,686	Oct 12 06:07 PM
Secora Michael	Chief Financial Officer	Oct 10 '23	Sale	7.07	25,000	176,762	900,686	Oct 12 06:07 PM
Gibson Christopher	Chief Executive Officer	Oct 04 '23	Option Exercise	2.48	31,250	77,500	902,541	Oct 06 06:12 PM
Gibson Christopher	Chief Executive Officer	Oct 04 '23	Sale	7.21	59,794	431,025	842,747	Oct 06 06:12 PM
Borgeson Blake	Director	Oct 03 '23	Sale	7.29	8,885	64,778	7,434,075	Oct 05 06:25 PM
Larson Tina Marriott	President and COO	Sep 28 '23	Option Exercise	1.06	3,000	3,180	421,782	Oct 02 06:19 PM
Larson Tina Marriott	President and COO	Sep 28 '23	Sale	7.72	3,000	23,159	418,782	Oct 02 06:19 PM
Borgeson Blake	Director	Sep 19 '23	Sale	8.36	8,885	74,278	7,442,960	Sep 21 06:35 PM
Virani Shafique	Chief Business Officer	Sep 15 '23	Option Exercise	2.22	18,000	39,960	158,351	Sep 19 05:50 PM
Virani Shafique	Chief Business Officer	Sep 15 '23	Sale	8.66	18,000	155,880	140,351	Sep 19 05:50 PM
Secora Michael	Chief Financial Officer	Sep 13 '23	Option Exercise	2.22	37,500	83,250	913,186	Sep 14 06:26 PM
Secora Michael	Chief Financial Officer	Sep 13 '23	Sale	8.69	25,000	217,318	888,186	Sep 14 06:26 PM
Secora Michael	Chief Financial Officer	Sep 12 '23	Option Exercise	2.22	37,500	83,250	900,686	Sep 14 06:26 PM
Secora Michael	Chief Financial Officer	Sep 12 '23	Sale	8.43	25,000	210,632	875,686	Sep 14 06:26 PM
Gibson Christopher	Chief Executive Officer	Sep 06 '23	Option Exercise	2.48	31,250	77,500	905,056	Sep 08 05:01 PM
Gibson Christopher	Chief Executive Officer	Sep 06 '23	Sale	8.78	33,765	296,575	871,291	Sep 08 05:01 PM
Gibson Christopher	Chief Executive Officer	Sep 06 '23	Sale	8.83	25,000	220,867	0	Sep 08 05:01 PM
Borgeson Blake	Director	Sep 05 '23	Sale	8.79	8,885	78,136	7,451,845	Sep 07 07:02 PM
Larson Tina Marriott	President and COO	Aug 24 '23	Option Exercise	1.06	3,000	3,180	421,782	Aug 28 06:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RXRX

Recursion Pharmaceuticals Inc

Upgrade your FINVIZ experience